Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles

Updated on: August 27,2024

Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles

Updated on:August 27,2024

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J

Updated on: January 26,2024

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J

Updated on:January 26,2024

Researchers discover new brain tumor subtypes that may identify treatment for incurable brain cancer

by RCSI University of Medicine and Health SciencesTrend towards improved OS and increased response rate in TMEHighpatients following adjuvant treatment with pembrolizumab or PVSRIPO . A. TME com

Updated on: February 01,2024

Researchers discover new brain tumor subtypes that may identify treatment for incurable brain cancer

by RCSI University of Medicine and Health SciencesTrend towards improved OS and increased response rate in TMEHighpatients following adjuvant treatment with pembrolizumab or PVSRIPO . A. TME com

Updated on:February 01,2024

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many

Updated on: April 01,2024

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many

Updated on:April 01,2024

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on: January 26,2024

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on:January 26,2024

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on: January 11,2024

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on:January 11,2024

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa

Updated on: December 25,2023

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa

Updated on:December 25,2023

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Updated on: April 28,2024

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Updated on:April 28,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on: May 07,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on:May 07,2024

Cancerous brain tumor cells may be at 'critical point' between order and disorder, study suggests

by Noah Fromson,University of MichiganCredit: Justine Ross and Jacob Dwyer / Michigan MedicineGlioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clini

Updated on: January 22,2024

Cancerous brain tumor cells may be at 'critical point' between order and disorder, study suggests

by Noah Fromson,University of MichiganCredit: Justine Ross and Jacob Dwyer / Michigan MedicineGlioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clini

Updated on:January 22,2024

Researchers identify a new way to target treatment-resistant cancers

by Hayley Dunning,Imperial College LondonCredit: ICLAn international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.Che

Updated on: June 19,2024

Researchers identify a new way to target treatment-resistant cancers

by Hayley Dunning,Imperial College LondonCredit: ICLAn international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.Che

Updated on:June 19,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023